P

Inventor

VELAPARTHI UPENDER

US33 patents
⚠️ This page may combine multiple inventors who share the name “VELAPARTHI UPENDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

22 patents
US7534792B2May 19, 2009

Pyrrolotriazine kinase inhibitors

BRISTOL MYERS SQUIBB CO30 citations92
US7223757B2May 29, 2007

Tyrosine kinase inhibitors

BRISTOL MYERS SQUIBB CO16 citations91
US7232826B2Jun 19, 2007

Tyrosine kinase inhibitors

BRISTOL MYERS SQUIBB CO13 citations84
US7879855B2Feb 1, 2011

Pyrrolotriazine kinase inhibitors

BRISTOL MYERS SQUIBB CO10 citations83
US9556179B2Jan 31, 2017

Substituted imidazoles as casein kinase 1 D/E inhibitors

BRISTOL MYERS SQUIBB CO9 citations81
US11866430B2Jan 9, 2024

Naphthyridinone compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO3 citations73
US7081454B2Jul 25, 2006

Tyrosine kinase inhibitors

BRISTOL MYERS SQUIBB CO6 citations72
US10669272B2Jun 2, 2020

Substituted naphthyridinone compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO4 citations70
US7189716B2Mar 13, 2007

Tyrosine kinase inhibitors

BRISTOL MYERS SQUIBB CO4 citations62
US11713316B2Aug 1, 2023

Substituted naphthyridinone compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations59
US10954238B1Mar 23, 2021

Substituted naphthyridinone compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations59
US12492172B2Dec 9, 2025

Substituted quinazolinyl compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations51
US12454531B2Oct 28, 2025

Substituted piperazine derivatives useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations51
US9242967B2Jan 26, 2016

Substituted bicyclic heteroaryl compounds

BRISTOL MYERS SQUIBB CO0 citations51
US7470696B2Dec 30, 2008

Tyrosine kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations51
US11964973B2Apr 23, 2024

Substituted bicyclic compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations50
US9475817B2Oct 25, 2016

Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors

BRISTOL MYERS SQUIBB CO1 citations50
US10961239B2Mar 30, 2021

TGF beta receptor antagonists

BRISTOL MYERS SQUIBB CO0 citations49
US11584747B2Feb 21, 2023

Substituted pyridopyrimidinonyl compounds useful as T cell activators

BRISTOL MYERS SQUIBB CO0 citations48
US9598423B2Mar 21, 2017

Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors

BRISTOL MYERS SQUIBB CO0 citations45
US9273058B2Mar 1, 2016

Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors

BRISTOL MYERS SQUIBB CO1 citations45
US9956220B2May 1, 2018

Imidazo-pyridazine derivatives as casein kinase 1 δ/ϵ inhibitors

BRISTOL MYERS SQUIBB CO0 citations34

VELAPARTHI UPENDER

5 patents

RIGEL PHARMACEUTICALS INC

4 patents

AUSTIN JOEL FRANCIS

1 patent

WITTMAN MARK D

1 patent